Medical Health & Life Science Research News

Report explores the global urinary tract infection treatment market to grow at a CAGR of 2.15% during the period 2017-2021

Research analysts forecast the global urinary tract infection treatment market to grow at a CAGR of 2.15% during the period 2017-2021.

UTI is an infection occurred in any part of the urinary system. The infection mostly involves the lower part of the urinary tract.

UTI can be classified into different types depending on the portion of the urinary system affected. Women are comparatively at a higher risk of developing UTI as compared with men since the urethra of the women is comparatively smaller than men and is also closer to the anus.

This anatomical structure of the urinary tract in women increases the chances of transfer of the bacteria to the bladder. However, people of any sex and age can get affected by the disease.

Request sample copy of this report at:

Covered in this report

The report covers the present scenario and the growth prospects of the global urinary tract infection treatment market for 2017-2021. To calculate the market size, the report considers the sales of branded, off-label, and generic drugs.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Research report, Global Urinary Tract Infection Tre… Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Merck,
  • Bayer,
  • Johnson & Johnson,
  • Novartis

Other prominent vendors

  • Achaogen
  • Allergan
  • Aquinox Pharmaceuticals
  • AstraZeneca
  • Lipella Pharmaceuticals
  • MediciNova
  • MerLion Pharma
  • Mylan
  • Novo Nordisk
  • Shionogi
  • Sun Pharmaceuticals
  • Teva Pharmaceutical Industries
  • Urigen
  • Zavante Therapeutics

Market driver

  • Relation of UTI with several other factors leading to rising incidence rate of UTI
  • For a full, detailed list, view our report

Market challenge

  • Development of antibacterial resistance
  • For a full, detailed list, view our report

Market trend

  • Growing awareness of controlled usage of antibiotics
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Companies Mentioned:

Merck, Bayer, Johnson & Johnson, Novartis, Achaogen, Allergan, Aquinox Pharmaceuticals, AstraZeneca, Lipella Pharmaceuticals, MediciNova, MerLion Pharma, Mylan, Novo Nordisk, Shionogi, Sun Pharmaceuticals, Teva Pharmaceutical Industries, Urigen, and Zavante Therapeutics.



News From

Orbis Research - Rendering Conscientious ResearchOrbis Research
Category: Market Research Publishers and RetailersCompany about: Orbis Research ( is a single point aid for all your market research requirements. We have a vast database of reports from the leading publishers and authors across the gl obe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their need, and we produce the perfect requi ...
This email address is being protected from spambots. You need JavaScript enabled to view it.